Long-Term Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration: A Belgian Subanalysis from the Global Real-World LUMINOUSTM Study

Anita M Leys,1,2 Eva Ramboer,3 Mérédis Favreau,3 Kris Denhaerynck,4,5 Karen MacDonald,4 Ivo Abraham,4,6– 8 Heidi Brié3 1Department of Ophthalmology, Universitair Ziekenhuis Gasthuisberg, KULeuven, Leuven, Belgium; 2Oogartsen, Alken, Belgium; 3Novartis Pharma, Vilvoorde, Belgium; 4Matrix45, Tucson, AZ, USA; 5Department of Public Health, University of Basel, Basel, Switzerland; 6Center for Health Outcomes and Pharmacoeconomic Research, University of Arizona, Tucson, AZ, USA; 7Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, AZ, USA; 8Department of... Mehr ...

Verfasser: Leys,Anita M
Ramboer,Eva
Favreau,Mérédis
Denhaerynck,Kris
MacDonald,Karen
Abraham,Ivo
Brié,Heidi
Dokumenttyp: Original Research
Erscheinungsdatum: 2020
Verlag/Hrsg.: Dove Press
Schlagwörter: Clinical Ophthalmology
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26501717
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://www.dovepress.com/long-term-ranibizumab-treatment-in-neovascular-age-related-macular-deg-peer-reviewed-fulltext-article-OPTH